Early Detection of Circulating Tumor DNA Postoperatively Enables Discovery of Resectable Metastatic Disease in a Patient with Colon Cancer

Currently, serum carcinoembryonic agent (CEA) along with contrast-enhanced imaging and colonoscopy are used for evaluation of recurrence of colorectal cancer. However, CEA is an unreliable and nonspecific biomarker that may fail to rise and signal relapse. Analysis of circulating tumor DNA (ctDNA) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinberg, Benjamin A., Winslow, Emily R., Bayasi, Mohammed, Krainock, Michael R., Olshan, Perry M., Billings, Paul R., Aleshin, Alexey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739946/
https://www.ncbi.nlm.nih.gov/pubmed/35082635
http://dx.doi.org/10.1159/000520743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739946/
https://www.ncbi.nlm.nih.gov/pubmed/35082635
http://dx.doi.org/10.1159/000520743

Ejemplares similares